1. ALA4296184 F Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600) Staphylococcus aureus 4,588 organism-based format CO-ADD antimicrobial screening data 2. ALA4296185 F Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600) Escherichia coli 4,585 organism-based format CO-ADD antimicrobial screening data 3. ALA4296186 F Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600) Klebsiella pneumoniae 6,160 organism-based format CO-ADD antimicrobial screening data 4. ALA4296187 F Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600) Pseudomonas aeruginosa 24,161 organism-based format CO-ADD antimicrobial screening data 5. ALA4296188 F Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600 Acinetobacter baumannii 22,588 organism-based format CO-ADD antimicrobial screening data 6. ALA4296189 F Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630 Candida albicans 6,134 organism-based format CO-ADD antimicrobial screening data 7. ALA4296190 F Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570) Cryptococcus neoformans 6,133 organism-based format CO-ADD antimicrobial screening data 8. ALA4296191 F Cytotoxicity against HEK293 cells (CO-ADD:MA_007); CC50 by cell viability assay in DMEM (10% FBS) media using TC plates, by Resazurin F(560/590) Homo sapiens 899 cell-based format CO-ADD antimicrobial screening data 9. ALA4296784 F Haemolysis of human Red Blood Cells (CO-ADD:HA_150); HC10, by OD(450) Homo sapiens 490 cell-based format CO-ADD antimicrobial screening data 10. ALA4296802 F Antibacterial activity against Pseudomonas aeruginosa PAO397 [PAO1 d(mexAB-oprM) d(mexCD-oprJ) d(mexEF-oprN) d(mexJKL) d(mexXY) d(opmH)] (CO-ADD:GN_211); MIC in CAMBH media using NBS plates, by OD(600) Pseudomonas aeruginosa 18,406 organism-based format CO-ADD antimicrobial screening data 11. ALA5136537 F Antibacterial activity against cystic fibrosis isolate Staphylococcus aureus by CLSI method Staphylococcus aureus 16 organism-based format Scientific Literature 12. ALA5136538 F Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI method Staphylococcus aureus 16 organism-based format Scientific Literature 13. ALA5136539 F Antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 by CLSI method Staphylococcus aureus 16 organism-based format Scientific Literature 14. ALA5136540 F Antibacterial activity against Staphylococcus aureus 3527 by CLSI method Staphylococcus aureus 16 organism-based format Scientific Literature 15. ALA5136541 F Antibacterial activity against Staphylococcus aureus harbouring GyrA D83N mutant by CLSI method Staphylococcus aureus 16 organism-based format Scientific Literature 16. ALA5136542 B Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity incubated for 25 min by ethidium bromide/bromophenol blue staining based agarose gel electrophoresis analysis Staphylococcus aureus 15 protein complex format Scientific Literature 17. ALA5136543 B Inhibition of Staphylococcus aureus DNA topoisomerase 4 decatenation activity using kDNA as substrate incubated for 10 to 20 min by ethidium bromide/bromophenol blue staining based agarose gel electrophoresis analysis Staphylococcus aureus 15 protein complex format Scientific Literature 18. ALA5136544 B Selectivity ratio of IC50 for inhibition of Staphylococcus aureus DNA topoisomerase 4 decatenation activity to IC50 for inhibition of Staphylococcus aureus DNA gyrase supercoiling activity Staphylococcus aureus 15 assay format Scientific Literature